Author:
Shenoy Bhaskar,Joshi Devesh N,Doddikoppad Pooja
Publisher
Jaypee Brothers Medical Publishing
Reference18 articles.
1. 1. Gardete S, Tomasz A. Mechanisms of vancomycin resistance in Staphylococcus aureus. J Clin Invest 2014;124(7):2836–2840. DOI: 10.1172/JCI68834
2. 2. Carreno JJ, Kenney RM, Lomaestro B. Vancomycin-associated renal dysfunction: where are we now? Pharmacotherapy 2014;34(12): 1259–1268. DOI: 10.1002/phar.1488
3. 3. “Goodman and Gilman's THE PHARMACOLOGICAL BASIS OF THERAPEUTICS”. THIRTEENTH EDITION, Laurence L. Brunton, et al. Volume 1. p. 1059.
4. 4. Duffull SB, Begg EJ. Vancomycin toxicity: what is the evidence for dose dependency? Adverse Drug React Toxicol Rev 1994;13(2):103–114. PMID: 7918897.
5. 5. Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the infectious diseases society of America, and the society of infectious diseases pharmacists. Am J Health Syst Pharm 2009;66(1):82–98. DOI: 10.2146/ajhp080434